Skip to main content

Advertisement

SpringerLink
Log in

The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to evaluate radiotherapy in terms of both feasibility and efficacy for the treatment of 206 elderly patients (≥70 years) with unresectable ESCC and to investigate the factors that predict overall survival in those patients.

Methods

Totally, 206 elderly patients with esophageal cancer (≥70 years) treated with RT for ESCC in the Harbin Medical University Affiliated Tumor Hospital were retrospectively enrolled. Radiation treatment results and side effects were evaluated. Survival data were estimated using the Kaplan–Meier method, including OS, RFS and DDFS. A multivariate Cox regression analysis was performed to determine the relevant prognostic factors.

Results

The median OS and RFS were 20.68 and 24.19 months. Metastases before radiotherapy, having cervical or supraclavicular neoplasm, with lesion length >5 cm were the independent risk factors for OS. The total effective rate was 86.9% (179/206).

Conclusion

Radiation therapy in elderly patients (≥70 years) can not only obtain good treatment result, but also make patients have better tolerance and reduce the risk of complications. Radiotherapy should be as a primary treatment option for elderly patients with inoperable ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liu G-F, Chang H, Li B-T, Zhang Y, Li D-D, Liu Y, et al. Effect of recombinant human endostatin on radiotherapy for esophagus cancer. Asian Pac J Trop Med. 2015;9:86–90.

    Article  PubMed  Google Scholar 

  2. Shafaee A, Dastyar DZ, Islamian JP, Hatamian M. Inhibition of tumor energy pathways for targeted esophagus cancer therapy. Metabolism. 2015;64(10):1193–8.

    Article  CAS  PubMed  Google Scholar 

  3. Haefner MF, Lang K, Krug D, Koerber SA, Uhlmann L, Kieser M, et al. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy. J Radiat Res. 2015;56(4):742–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003. Int J Cancer. 2008;123(6):1422–8.

    Article  CAS  PubMed  Google Scholar 

  5. Wiedmann MW, Mössner J. Esophageal cancer: molecular mechanisms, diagnosis and treatment. In: International Manual of Oncology Practice. Springer; 2015. pp. 201–228.

  6. Tougeron D, Hamidou H, Scotte M, Flore FD, Antonietti M, Paillot B, et al. Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 2010;10(1):1.

    Article  Google Scholar 

  7. Sabel, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol. 2002;9(2):210–4.

    Article  PubMed  Google Scholar 

  8. Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2007;25(17):2389–96.

    Article  PubMed  Google Scholar 

  9. Jing W, Zhu H, Guo H, Zhang Y, Shi F, Han A, et al. Feasibility of elective nodal irradiation (ENI) and involved field irradiation (IFI) in radiotherapy for the elderly patients (aged ≥ 70 years) with esophageal squamous cell cancer: a retrospective analysis from a single institute. PLoS ONE. 2015;10(12):e0143007.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA. 1999;281(17):1623–7.

    Article  CAS  PubMed  Google Scholar 

  11. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–8.

    Article  CAS  PubMed  Google Scholar 

  12. Wang X, Li G, Zhang Y, Bai S, Xu F, Wei Y, et al. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT). Med Dosim. 2013;38(4):395–400.

    Article  PubMed  Google Scholar 

  13. Chen C-Z, Chen J-Z, Li D-R, Lin Z-X, Zhou M-Z, Li D-S, et al. Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy. World J Gastroenterol. 2013;19(10):1639.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Fritz P, Kraus H-J, Muhlnickel W, Hammer U, Dolken W, Engel-Riedel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol. 2006;1(1):1.

    Article  Google Scholar 

  15. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186–96.

    Article  PubMed  Google Scholar 

  16. Xu Y, Zheng Y, Sun X, Yu X, Gu J, Wu W, et al. Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: preliminary results of a phase II study. Oncotarget. 2015;6(35):38429–39.

    PubMed  PubMed Central  Google Scholar 

  17. Kawashima M, Kagami Y, Toita T, Uno T, Sugiyama M, Tamura Y, et al. Prospective trial of radiotherapy for patients 80 years of age or older with squamous cell carcinoma of the thoracic esophagus. Int J Radiat Oncol Biol Phys. 2006;64(4):1112–21.

    Article  PubMed  Google Scholar 

  18. Rizk NP, Venkatraman E, Bains MS, Park B, Flores R, Tang L, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol. 2007;25(5):507–12.

    Article  PubMed  Google Scholar 

  19. Iizuka T, Isono K, Kakegawa T, Watanabe H. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma Cases. Chest. 1989;96(5):1005–11.

    Article  CAS  PubMed  Google Scholar 

  20. Sobin LH, Hermanek P, Hutter RV. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer. 1988;61(11):2310–4.

    Article  CAS  PubMed  Google Scholar 

  21. Wijnhoven BP, Tran KT, Esterman A, Watson D, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245(5):717–25.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Griffiths EA, Brummell Z, Gorthi G, et al. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol. 2006;93(4):258–67.

    Article  PubMed  Google Scholar 

  23. Bolton WD, Wayne L, Ashleigh M, Francis BS, Correa AM, et al. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009;138(4):831–6.

    Article  PubMed  Google Scholar 

  24. Deantonio L, Masini L, Brambilla M, Pia F, Krengli M. Dysphagia after definitive radiotherapy for head and neck cancer. Strahlenther Onkol. 2013;189(3):230–7.

    Article  CAS  PubMed  Google Scholar 

  25. Haderlein M, Semrau S, Ott O, Speer S, Bohr C, Fletkau R. Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer. Strahlenther Onkol. 2014;190(2):192–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

There is no funds for The authors′ work.

Author information

Authors and Affiliations

  1. Radiation Oncology Division, Harbin Medical University Affiliated Tumor Hospital, Harbin, Heilongjiang, China

    H. Yin, M. E & C. Wang

  2. Breast Surgery Ward Three, Harbin Medical University Affiliated Tumor Hospital, Harbin, Heilongjiang, China

    H. Zhang

Authors
  1. H. Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. E
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. E.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yin, H., E, M., Zhang, H. et al. The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma. Clin Transl Oncol 19, 742–749 (2017). https://doi.org/10.1007/s12094-016-1603-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-016-1603-0

Keywords

Search

Navigation